 | • レポートコード：QYR9ST04869 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、B型肝炎ウイルス（HBV）の世界市場について調査・分析し、B型肝炎ウイルス（HBV）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（治療薬、ワクチン）、用途別（病院、外来手術センター、診断センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のB型肝炎ウイルス（HBV）市場動向 ・主要企業別マーケットシェア ・B型肝炎ウイルス（HBV）の種類別市場規模2014-2019 （治療薬、ワクチン） ・B型肝炎ウイルス（HBV）の用途別市場規模2014-2019 （病院、外来手術センター、診断センター） ・B型肝炎ウイルス（HBV）の北米市場：主要企業・種類別/用途別市場規模 ・B型肝炎ウイルス（HBV）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・B型肝炎ウイルス（HBV）の中国市場：主要企業・種類別/用途別市場規模 ・B型肝炎ウイルス（HBV）の日本国内市場：主要企業・種類別/用途別市場規模 ・B型肝炎ウイルス（HBV）の東南アジア市場：主要企業・種類別/用途別市場規模 ・B型肝炎ウイルス（HBV）のインド市場：主要企業・種類別/用途別市場規模 ・B型肝炎ウイルス（HBV）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、Gilead Sciences、Novartis、GlaxoSmithKline、Hoffmann、La Roche、Bristol-Myers Squibb） ・B型肝炎ウイルス（HBV）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.
In 2018, the global Hepatitis B Vir (HBV) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hepatitis B Vir (HBV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B Vir (HBV) development in United States, Europe and China.
The key players covered in this study
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
…
Market segment by Type, the product can be split into
Therapeutics
Vaccine
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Hepatitis B Vir (HBV) status, future forecast, growth opportunity, key market and key players.
To present the Hepatitis B Vir (HBV) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hepatitis B Vir (HBV) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hepatitis B Vir (HBV) Market Size Growth Rate by Type (2014-2025)
1.4.2 Therapeutics
1.4.3 Vaccine
1.5 Market by Application
1.5.1 Global Hepatitis B Vir (HBV) Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hepatitis B Vir (HBV) Market Size
2.2 Hepatitis B Vir (HBV) Growth Trends by Regions
2.2.1 Hepatitis B Vir (HBV) Market Size by Regions (2014-2025)
2.2.2 Hepatitis B Vir (HBV) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hepatitis B Vir (HBV) Market Size by Manufacturers
3.1.1 Global Hepatitis B Vir (HBV) Revenue by Manufacturers (2014-2019)
3.1.2 Global Hepatitis B Vir (HBV) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hepatitis B Vir (HBV) Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis B Vir (HBV) Key Players Head office and Area Served
3.3 Key Players Hepatitis B Vir (HBV) Product/Solution/Service
3.4 Date of Enter into Hepatitis B Vir (HBV) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hepatitis B Vir (HBV) Market Size by Type (2014-2019)
4.2 Global Hepatitis B Vir (HBV) Market Size by Application (2014-2019)
5 United States
5.1 United States Hepatitis B Vir (HBV) Market Size (2014-2019)
5.2 Hepatitis B Vir (HBV) Key Players in United States
5.3 United States Hepatitis B Vir (HBV) Market Size by Type
5.4 United States Hepatitis B Vir (HBV) Market Size by Application
6 Europe
6.1 Europe Hepatitis B Vir (HBV) Market Size (2014-2019)
6.2 Hepatitis B Vir (HBV) Key Players in Europe
6.3 Europe Hepatitis B Vir (HBV) Market Size by Type
6.4 Europe Hepatitis B Vir (HBV) Market Size by Application
7 China
7.1 China Hepatitis B Vir (HBV) Market Size (2014-2019)
7.2 Hepatitis B Vir (HBV) Key Players in China
7.3 China Hepatitis B Vir (HBV) Market Size by Type
7.4 China Hepatitis B Vir (HBV) Market Size by Application
8 Japan
8.1 Japan Hepatitis B Vir (HBV) Market Size (2014-2019)
8.2 Hepatitis B Vir (HBV) Key Players in Japan
8.3 Japan Hepatitis B Vir (HBV) Market Size by Type
8.4 Japan Hepatitis B Vir (HBV) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hepatitis B Vir (HBV) Market Size (2014-2019)
9.2 Hepatitis B Vir (HBV) Key Players in Southeast Asia
9.3 Southeast Asia Hepatitis B Vir (HBV) Market Size by Type
9.4 Southeast Asia Hepatitis B Vir (HBV) Market Size by Application
10 India
10.1 India Hepatitis B Vir (HBV) Market Size (2014-2019)
10.2 Hepatitis B Vir (HBV) Key Players in India
10.3 India Hepatitis B Vir (HBV) Market Size by Type
10.4 India Hepatitis B Vir (HBV) Market Size by Application
11 Central & South America
11.1 Central & South America Hepatitis B Vir (HBV) Market Size (2014-2019)
11.2 Hepatitis B Vir (HBV) Key Players in Central & South America
11.3 Central & South America Hepatitis B Vir (HBV) Market Size by Type
11.4 Central & South America Hepatitis B Vir (HBV) Market Size by Application
12 International Players Profiles
12.1 Merck
12.1.1 Merck Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hepatitis B Vir (HBV) Introduction
12.1.4 Merck Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.1.5 Merck Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hepatitis B Vir (HBV) Introduction
12.2.4 Gilead Sciences Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.2.5 Gilead Sciences Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hepatitis B Vir (HBV) Introduction
12.3.4 Novartis Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hepatitis B Vir (HBV) Introduction
12.4.4 GlaxoSmithKline Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.4.5 GlaxoSmithKline Recent Development
12.5 Hoffmann
12.5.1 Hoffmann Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hepatitis B Vir (HBV) Introduction
12.5.4 Hoffmann Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.5.5 Hoffmann Recent Development
12.6 La Roche
12.6.1 La Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hepatitis B Vir (HBV) Introduction
12.6.4 La Roche Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.6.5 La Roche Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hepatitis B Vir (HBV) Introduction
12.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Vir (HBV) Business (2014-2019)
12.7.5 Bristol-Myers Squibb Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Hepatitis B Vir (HBV) Key Market Segments
Table Key Players Hepatitis B Vir (HBV) Covered
Table Global Hepatitis B Vir (HBV) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hepatitis B Vir (HBV) Market Size Market Share by Type 2014-2025
Figure Therapeutics Figures
Table Key Players of Therapeutics
Figure Vaccine Figures
Table Key Players of Vaccine
Table Global Hepatitis B Vir (HBV) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Diagnostic Centers Case Studies
Figure Hepatitis B Vir (HBV) Report Years Considered
Table Global Hepatitis B Vir (HBV) Market Size 2014-2025 (Million US$)
Figure Global Hepatitis B Vir (HBV) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hepatitis B Vir (HBV) Market Size by Regions 2014-2025 (Million US$)
Table Global Hepatitis B Vir (HBV) Market Size by Regions 2014-2019 (Million US$)
Table Global Hepatitis B Vir (HBV) Market Share by Regions 2014-2019
Figure Global Hepatitis B Vir (HBV) Market Share by Regions 2014-2019
Figure Global Hepatitis B Vir (HBV) Market Share by Regions 2019
Table Market Top Trends
Table Global Hepatitis B Vir (HBV) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hepatitis B Vir (HBV) Market Share by Manufacturers (2014-2019)
Figure Global Hepatitis B Vir (HBV) Market Share by Manufacturers in 2018
Table Global Hepatitis B Vir (HBV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hepatitis B Vir (HBV) Product/Solution/Service
Table Date of Enter into Hepatitis B Vir (HBV) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table Global Hepatitis B Vir (HBV) Market Size Share by Type (2014-2019)
Figure Global Hepatitis B Vir (HBV) Market Size Market Share by Type (2014-2019)
Table Global Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table Global Hepatitis B Vir (HBV) Market Size Share by Application (2014-2019)
Figure Global Hepatitis B Vir (HBV) Market Size Market Share by Application (2014-2019)
Figure Global Hepatitis B Vir (HBV) Revenue Market Share by Application in 2018
Figure United States Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table United States Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table United States Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table United States Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table United States Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table United States Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table United States Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Figure Europe Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table Europe Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table Europe Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table Europe Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table Europe Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table Europe Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table Europe Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Figure China Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table China Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table China Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table China Hepatitis B Vir (HBV) Market Size by Type (2014-20189) (Million US$)
Table China Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table China Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table China Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Figure Japan Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table Japan Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table Japan Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table Japan Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table Japan Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table Japan Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table Japan Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Figure Southeast Asia Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table Southeast Asia Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table Southeast Asia Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Figure India Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table India Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table India Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table India Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table India Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table India Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table India Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Figure Central & South America Hepatitis B Vir (HBV) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hepatitis B Vir (HBV) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hepatitis B Vir (HBV) Market Share (2018-2019)
Table Central & South America Hepatitis B Vir (HBV) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hepatitis B Vir (HBV) Market Share by Type (2014-2019)
Table Central & South America Hepatitis B Vir (HBV) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hepatitis B Vir (HBV) Market Share by Application (2014-2019)
Table Merck Company Details
Table Merck Revenue in Hepatitis B Vir (HBV) Business (2014-2019) (Million US$)
Figure Merck Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table Merck Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Hepatitis B Vir (HBV) Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table Gilead Sciences Recent Development
Table Novartis Company Details
Table Novartis Revenue in Hepatitis B Vir (HBV) Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table Novartis Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Hepatitis B Vir (HBV) Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Hoffmann Company Details
Table Hoffmann Revenue in Hepatitis B Vir (HBV) Business (2014-2019)(Million US$)
Figure Hoffmann Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table Hoffmann Recent Development
Table La Roche Company Details
Table La Roche Revenue in Hepatitis B Vir (HBV) Business (2014-2019)(Million US$)
Figure La Roche Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table La Roche Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Hepatitis B Vir (HBV) Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Vir (HBV) Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Hepatitis B Vir (HBV) Market Size by Regions (Million US$) 2019-2025
Figure Global Hepatitis B Vir (HBV) Market Size Share by Regions (2019-2025)
Figure Global Hepatitis B Vir (HBV) Market Size Share by Regions in 2025
Figure United States Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Figure China Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Figure India Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hepatitis B Vir (HBV) Market Size Forecast (2019-2025)(Million USD)
Table Global Hepatitis B Vir (HBV) Market Size by Product (2019-2025) (Million US$)
Figure Global Hepatitis B Vir (HBV) Market Size by Product (2019-2025)
Figure Global Hepatitis B Vir (HBV) Market Size by Product in 2025
Table Global Hepatitis B Vir (HBV) Market Size by Application (2019-2025) (Million US$)
Figure Global Hepatitis B Vir (HBV) Market Size by Application (2019-2025)
Figure Global Hepatitis B Vir (HBV) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
C型肝炎ウイルス（HCV）の世界市場：市場規模・現状・予測 Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…- 肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…
- 肝炎治療薬の世界市場：市場規模・現状・予測 Hepatitis therapeutics are a serial treatment methods targeting on Hepatitis A, Hepatitis B,Hepatitis C and Alcoholic Hepatitis.With the number of hepatitis patients increasing and more governments concern about hepatitis and its control, hepatitis therapeutics has large potential market value and w…
- E型肝炎診断検査の世界市場：市場規模・現状・予測 Hepatitis E is a virus that affects your liver.In 2018, the global Hepatitis E Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hepatitis E Diagnostic Tests status, fu…
- C型肝炎ウイルス及び治療薬の世界市場：市場規模・現状・予測 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinomaIn 2018, the global Hepatitis C Virus And Therapeutics market size was xx million US$ and it is ex…